RU2009141168A - Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна - Google Patents

Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна Download PDF

Info

Publication number
RU2009141168A
RU2009141168A RU2009141168/15A RU2009141168A RU2009141168A RU 2009141168 A RU2009141168 A RU 2009141168A RU 2009141168/15 A RU2009141168/15 A RU 2009141168/15A RU 2009141168 A RU2009141168 A RU 2009141168A RU 2009141168 A RU2009141168 A RU 2009141168A
Authority
RU
Russia
Prior art keywords
desmethylvenlafaxine
agent
duloxetine
patient
respiratory
Prior art date
Application number
RU2009141168/15A
Other languages
English (en)
Russian (ru)
Inventor
Дин А. ХЕНДЛИ (US)
Дин А. ХЕНДЛИ
Ларри У. ХАРДИ (US)
Ларри У. ХАРДИ
Мердад Варизи ПАРСИ (US)
Мердад Варизи ПАРСИ
Original Assignee
Сепракор Инк. (Us)
Сепракор Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сепракор Инк. (Us), Сепракор Инк. filed Critical Сепракор Инк. (Us)
Publication of RU2009141168A publication Critical patent/RU2009141168A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/14Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2009141168/15A 2007-04-09 2008-04-08 Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна RU2009141168A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
US60/922,466 2007-04-09

Publications (1)

Publication Number Publication Date
RU2009141168A true RU2009141168A (ru) 2011-05-20

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009141168/15A RU2009141168A (ru) 2007-04-09 2008-04-08 Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна

Country Status (15)

Country Link
US (3) US20080293823A1 (https=)
EP (2) EP2455076A1 (https=)
JP (1) JP2010523662A (https=)
KR (1) KR20100015923A (https=)
CN (1) CN101686955A (https=)
AR (1) AR065989A1 (https=)
AU (1) AU2008236624A1 (https=)
BR (1) BRPI0810159A2 (https=)
CA (1) CA2683697C (https=)
IL (1) IL201430A0 (https=)
MX (1) MX2009010805A (https=)
NZ (1) NZ580250A (https=)
RU (1) RU2009141168A (https=)
TW (1) TW200901956A (https=)
WO (1) WO2008124128A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012007813A (es) * 2010-01-07 2012-08-01 Vivus Inc Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
EP3746126B1 (en) 2018-01-30 2024-07-31 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea or simple snoring
EP4635514A3 (en) * 2019-02-08 2025-12-24 The Brigham & Women's Hospital, Inc. Methods and compositions for treating sleep apnea

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US6110973A (en) 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
DE60039132D1 (de) * 1999-04-06 2008-07-17 Sepracor Inc O-Desmethylvenlafaxin-Succinat
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
NZ548856A (en) * 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039867A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders with setiptiline
KR20070087678A (ko) * 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
AU2006255047B2 (en) * 2005-06-06 2011-09-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating sleep disorders
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
KR101528326B1 (ko) * 2007-02-21 2015-06-11 선오비온 파마슈티컬스 인코포레이티드 (―)o―데스메틸벤라팍신을 포함하는 고체 형태들 및 그들의 용도
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

Also Published As

Publication number Publication date
MX2009010805A (es) 2009-10-29
JP2010523662A (ja) 2010-07-15
TW200901956A (en) 2009-01-16
BRPI0810159A2 (pt) 2014-12-30
EP2142183A2 (en) 2010-01-13
US20150196531A1 (en) 2015-07-16
KR20100015923A (ko) 2010-02-12
CN101686955A (zh) 2010-03-31
AU2008236624A1 (en) 2008-10-16
AR065989A1 (es) 2009-07-15
IL201430A0 (en) 2010-05-31
US20080293823A1 (en) 2008-11-27
US20120238616A1 (en) 2012-09-20
WO2008124128A3 (en) 2009-05-07
NZ580250A (en) 2012-05-25
EP2455076A1 (en) 2012-05-23
WO2008124128A2 (en) 2008-10-16
CA2683697A1 (en) 2008-10-16
CA2683697C (en) 2016-08-16

Similar Documents

Publication Publication Date Title
US9254219B2 (en) Snoring and obstructive sleep apnea prevention and treatment device
US20120234332A1 (en) Snoring and obstructive sleep apnea prevention and treatment device
US9072613B2 (en) Device for snoring and obstructive sleep apnea treatment
CN103405843B (zh) 一种随体位变化调节呼气正压的通气面罩
US20080041397A1 (en) Article & method for inducing proper breathing during sleep cycles to reactivate bodily functions
RU2009141168A (ru) Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна
JP2010523662A5 (https=)
CN101530646A (zh) 带有咬口的胃镜用吸氧面罩
WO2005110052A3 (en) The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
CN212282480U (zh) 一种适合经鼻腔手术术后使用的氧气面罩
CN106038036A (zh) 可穿戴式呼吸机
CN204619095U (zh) 一种无痛胃镜吸氧面罩
CN204910376U (zh) 一次性气囊型输氧雾化器
CN203370011U (zh) 磁力阻鼾器
Murata et al. Laryngeal mask airway Supreme™ for asleep–awake–asleep craniotomy
CN206365972U (zh) 一种锁扣式阻鼾器
CN204192837U (zh) 一种止鼾器
CN221229778U (zh) 一种便于佩戴的湿化氧疗鼻导管
CN203425348U (zh) 一种随体位变化调节呼气正压的通气面罩
CN204581651U (zh) 一种改善打鼾的装置
TWI872958B (zh) 止鼾器
JP5467198B2 (ja) うつぶせ寝用枕
CN201618274U (zh) 一种用于呼吸机的口鼻罩
CN2525970Y (zh) 减鼾器
Lopez-Munoz et al. Yu Zhong1, Min Jiang2, Yunshi Wang1, Tingting Su1, Yuanzhi Lv1, Zhiqing Fan1, Hengyi Ning1, Yilan Yang1, Yanhua Chen3* and Yubo Xie1

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20121221